-
Study aim
-
Investigating the therapeutic role of vitamin D on dry eye parameters
-
Design
-
Randomized Clinical Trial without control group, Not blind Phase 2 was performed on 50 patients.
-
Settings and conduct
-
This study is based on the high prevalence of these two disorders in the community and with the aim of investigating the prevalence and relationship between dry eye and serum deficiency 25OHD and also examining the effect of vitamin D treatment on dry eye parameters, on 90 patients referred to endocrinology and ophthalmology clinic Jahrom medicine, which is also deficient in serum 25OHD and dry eye, should be performed.
-
Participants/Inclusion and exclusion criteria
-
Conditions for entering the study: Patients referring to the endocrinology clinic of Jahrom University of Medical Sciences with abnormal serum levels of 25OHD
Conditions for not entering the study: Patients with Ss (Sjogren's Syndrome) or with a history of other systemic rheumatic diseases, thyroid disease, vitamin A deficiency, glucocorticoid medications, antidepressants, contraceptives, estrogen, people with vitamin B12 deficiency, disorders and wearing contact lenses eye level, type 1 diabetes, pregnancy, lactation, a former eye surgery, age older than 50 years and those with higher baseline crp
-
Intervention groups
-
The study has a group that includes patients referring to the endocrinology clinic of Jahrom University of Medical Sciences. For people with serum levels of 25 hydroxyvitamin D3 less than 20 ng / ml, standard treatment with vitamin D (for 8 weeks each week, 50,000 units of vitamin D vitamin Zahravi) is started. After the end of the treatment period, the serum level of 25 hydroxyvitamin D3 and the dry eye parameters of all patients under study are checked again.
-
Main outcome variables
-
Tear breakup time test, Schirmer test results, Ocular Surface Disease Index score